Russia begins using the first domestic vaccine against birch pollen allergy
Published
Russia has launched the use of the first domestic vaccine designed to combat birch pollen allergy. This is an important development for people who suffer from a runny nose, sneezing and watery eyes every spring.
Birch pollen allergy is one of the most common spring allergies. When the birch begins to bloom, pollen enters the air and can cause unpleasant symptoms in sensitive people. For this reason, many patients try to prepare for the flowering season in advance.
The new vaccine is based on the method of allergen-specific immunotherapy. This means that small doses of the allergen are introduced into the body so that the immune system gradually gets used to it and reacts to pollen more weakly. This method has been used in medicine before, but this is the first time a domestic drug against birch pollen allergy has appeared in the country.
Before starting treatment, specialists usually advise consulting an allergist. A doctor will help determine whether the vaccine is suitable for a particular patient. The birch flowering season is already close, so interest in the new drug is growing.
Sources: Правда.Ру
More Russia news
- Russia Is Developing Its First Private Ultralight Launch Vehicle, Voronezh
- Positive Technologies increased shipments by 54% in the first nine months of 2026
- The Desire to Leave and Actual Emigration: Why the Gap Is So Large
- Putin Praises Belarus's Assistance in Humanitarian Exchanges
- Putin: Cooperation between Belarus and Russia Is Developing at a Good Pace
- Ukraine and G7 countries discuss protection against air strikes and sanctions against Russia
- The number of patients with respiratory diseases in Russia has risen by 30%
- One in Four Europeans Suffers from Mental Disorders